CHI3L1 and breast carcinoma: Moreover, CHI3L1 is amplified in 12–24% of primary tumors in all BC subtypes and in 6–12% of primary tumors in TNBC based on data from The Cancer Genome Atlas/TCGA and Molecular Taxonomy of Breast Cancer International Consortium/METABRIC (Additional file 17: Fig. S15A).